Effects of troglitazone on frequency of coronary vasospastic-induced angina pectoris in patients with diabetes mellitus

Citation
T. Murakami et al., Effects of troglitazone on frequency of coronary vasospastic-induced angina pectoris in patients with diabetes mellitus, AM J CARD, 84(1), 1999, pp. 92
Citations number
18
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
AMERICAN JOURNAL OF CARDIOLOGY
ISSN journal
00029149 → ACNP
Volume
84
Issue
1
Year of publication
1999
Database
ISI
SICI code
0002-9149(19990701)84:1<92:EOTOFO>2.0.ZU;2-6
Abstract
This study investigates the effects of troglitazone, an insulin sensitizer, on the clinical manifestation of coronary vasospastic angina pectoris in p atients with diabetes mellitus. Troglitazone reduces frequency of angina pe ctoris and improves endothelial function.